VASC Financial Facts
Operating earnings: 2.9MTotal product costs and operating expenses: 23.16M
See Full Income Statement
Goodwill: 10.31M
Cash and cash equivalents: 14.05M
See Full Balance Sheet
Earnings History for Vascular Solutions (VASC)
|
Expand Research on VASC
| Next EPS Date | 7/23/13 *Est. | EPS Growth Rate | +33.3% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +8.7% | Revenue Growth Rate | +9.7% *Last Qtr. |
| Average % Move 1-Wk after EPS | -1.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/23/13  |
Q113 | $0.16 | $0.15 | +$0.01 | $26.1M | $26.51M | N/A / N/A | = | -9.8% | Details | |
| 2/5/13 |
 |
Q412 | $0.18 | $0.17 | +$0.01 | $25.3M | $25.59M | N/A / N/A | = | -10% | Details |
| 10/18/12 |
|
Q312 | $0.16 | $0.15 | +$0.01 | $24.6M | $24.77M | N/A / N/A | = | +2.1% | Details |
| 7/24/12 |
|
Q212 | $0.15 | $0.13 | +$0.02 | $24.7M | $24.15M | N/A / N/A |  |
+18.2% | Details |
| 4/24/12 |
|
Q112 | $0.12 | $0.11 | +$0.01 | $23.8M | $22.51M | N/A / N/A | |
+41.9% | Details |
| 2/1/12 |
|
Q411 | $0.13 | $0.13 | $0.00 | $22.1M | $22.5M | N/A / N/A | |
0% | Details |
| 10/25/11 |
|
Q311 | $0.22 | $0.20 | +$0.02 | $24.3M | $25.07M | N/A / N/A | = | +26.6% | Details |
| 8/2/11 |
|
Q211 | $0.13 | $0.12 | +$0.01 | $22.3M | $22.47M | N/A / N/A | = | +18.8% | Details |
